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Abstract
While recent scans for genetic variation associated with human disease have been immensely successful in uncovering large
numbers of loci, far fewer studies have focused on the underlying pathways of disease pathogenesis. Many loci which are
associated with disease and complex phenotypes map to non-coding, regulatory regions of the genome, indicating that
modulation of gene transcription plays a key role. Thus, this study generated genome-wide profiles of both genetic and
transcriptional variation from the total blood extracts of over 500 randomly-selected, unrelated individuals. Using
measurements of blood lipids, key players in the progression of atherosclerosis, three levels of biological information are
integrated in order to investigate the interactions between circulating leukocytes and proximal lipid compounds. Pair-wise
correlations between gene expression and lipid concentration indicate a prominent role for basophil granulocytes and mast
cells, cell types central to powerful allergic and inflammatory responses. Network analysis of gene co-expression showed
that the top associations function as part of a single, previously unknown gene module, the Lipid Leukocyte (LL) module.
This module replicated in T cells from an independent cohort while also displaying potential tissue specificity. Further,
genetic variation driving LL module expression included the single nucleotide polymorphism (SNP) most strongly
associated with serum immunoglobulin E (IgE) levels, a key antibody in allergy. Structural Equation Modeling (SEM)
indicated that LL module is at least partially reactive to blood lipid levels. Taken together, this study uncovers a gene
network linking blood lipids and circulating cell types and offers insight into the hypothesis that the inflammatory response
plays a prominent role in metabolism and the potential control of atherogenesis.
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Introduction
Blood lipid levels have long been known to be important
markers of coronary artery disease and the underlying pathology
of atherosclerosis [1,2]. High-density lipoprotein cholesterol
(HDL) is a small, dense complex of phospholipids and apolipo-
proteins, including apolipoprotein A1 (APOA1), which is synthe-
sized in the liver and has been shown to be negatively associated
with atherogenesis. Low-density lipoprotein cholesterol (LDL)
displays a positive association with atherogenesis and contains one
apolipoprotein, apolipoprotein B (APOB), as well as numerous
fatty acids, lipids, and cholesterols. Atherosclerosis entails the
buildup of LDL deposits in the arterial wall where they undergo
oxidation and subsequent internalization by macrophages, an
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further inflammatory signals which can exacerbate arterial LDL
adhesion, leading to stenosis [3].
Genome-wide association studies (GWAS) have yielded many
successes in the search for the common genetic variants
underlying blood lipid levels and other metabolic traits [4–7],
however systematic functional investigation of pathways, partic-
ularly lipid pathways, has lagged behind. Recently, the link
between the inflammatory response and metabolism has been
the subject of intense research [8,9]. Chronic inflammation has
been shown to lead to the activation of c-Jun amino-terminal
kinases [10,11], and plasma triglyceride levels have been
associated with various mediators of NF-KB, a key component
of the immune response [12–15]. Further, it has been shown
that postprandial triglyceride increase activates monocytes and
neutrophils and the cardioprotective properties of HDL might
be partially mediated by activation of the complement cascade
[16,17]. Recently, two companion studies demonstrated both an
enrichment of immune pathways in metabolic syndrome and the
utility of integrating genomic and transcriptional variation
[18,19]. In particular, they identify a gene expression network
of macrophage origin which is likely to be causative of various
metabolic traits.
The proximity of lipid compounds and leukocytes in peripheral
blood offers a uniquely accessible system in which to study their
interactions. We utilized total blood samples from a population-
based cohort of 518 unrelated individuals (240 males and 278
females, aged 25–74 years) from the Dietary, Lifestyle, and
Genetic determinants of Obesity and Metabolic syndrome
(DILGOM) study which have undergone both genome-wide
expression profiling and genome-wide genotyping with imputa-
tion. After quality filtering (Materials and Methods), 35,419
expression probes and 541,654 SNPs (2,061,516 SNPs after
imputation) were taken forward for further analyses. We first
assessed how single gene expression correlated with both the
specific lipid measurements of the DILGOM cohort and overall
variation in lipids (Table 1) then performed network analyses to
identify and characterize clusters of tightly co-expressed genes,
modules, which showed strong association with lipids. Replication
and tissue specificity of a particular module, termed the Lipid
Leukocyte (LL) module, was investigated in an independent cohort
of B cells and T cells. Finally, genetic variation was assessed both
to identify expression quantitative trait loci (eQTLs) driving
expression of LL module, thus connecting our findings with that of
a previously published GWAS, and to construct an edge-oriented
network to elucidate the chain of causality.
Results and Discussion
To assess how each lipid trait associated with gene expression,
levels of HDL, LDL, APOB, APOA1, total serum cholesterol
(TC), triglycerides (TG), and free fatty acids (FFA) were modeled
using multiple linear regression with appropriate covariates
(Table 2) and a Bonferroni adjusted significance level for each
trait, equivalent to a nominal P=1.41610
26. Models were fitted
with and without hypertension and cholesterol lowering medica-
tions as covariates; no difference in the results was found. Since
there are known gender-specific effects, traits were gender-
stratified and standardized to Z-scores. Overall, 49 significant
associations with gene expression were found (Table 3), however
none were observed for TC, LDL, or APOA1. All reported P
values are Bonferroni adjusted.
Mediators of inflammation and allergy are associated
with APOB, HDL, and TG levels
The strongest signals for FFA were from genes previously
known to be involved in b-oxidation and lipolysis. During fatty
acid metabolism, long-chain acyl groups are transported from the
cytosol into the mitochondrial matrix by carnitine. At the outer
mitochondrial membrane, acyl groups are attached to carnitine by
Table 1. Lipid traits of the DILGOM population sample.
Trait Units
Overall mean
(s.d.)
Male mean
(s.d.)
Female mean
(s.d.)
TC mmol/L 5.11 (0.95) 5.09 (0.95) 5.13 (0.95)
LDL mmol/L 3.07 (0.84) 3.17 (0.84) 2.98 (0.83)
HDL mmol/L 1.48 (0.36) 1.34 (0.30) 1.61 (0.36)
APOA1 g/L 1.63 (0.28) 1.53 (0.25) 1.72 (0.28)
APOB g/L 0.92 (0.21) 0.95 (0.21) 0.89 (0.20)
TG mmol/L 1.15 (0.64) 1.27 (0.78) 1.04 (0.47)
FFA mmol/L 0.36 (0.21) 0.33 (0.20) 0.38 (0.22)
doi:10.1371/journal.pgen.1001113.t001
Table 2. Multiple regression covariates.
TRAIT Abbrev. COVARIATES
Total serum cholesterol TC Age CM HTM
High density lipoprotein HDL Age CM HTM Alcohol
Low density lipoprotein LDL Age CM HTM Alcohol
Apolipoprotein A1 APOA1 Age CM HTM
Apolipoprotein B APOB Age CM HTM
Triglycerides TG Age CM HTM Alcohol
Free fatty acids FFA Age CM HTM
Meta-lipids - Age CM HTM Alcohol
CM=cholesterol lowering medication (Yes or No).
HTM=hypertension medication (Yes or No).
Alcohol=alcohol intake in previous 7 days (grams).
For those DILGOM individuals passing quality control (N=518), the proportion
using HTM was 20.5% (18.7% of females, 22.5% of males) and the proportion
using CM was 14.3% (10.1% of females, 19.2% of males).
doi:10.1371/journal.pgen.1001113.t002
Author Summary
Circulating lipid concentrations are important predictors of
coronary artery disease. The main pathology of coronary
artery disease is atherosclerosis, a cycle of lipid adherence
to the walls of arteries and an inflammatory response
resulting in more adhesion. To investigate the link
between lipids and immune cells in circulation, we have
generated both genomic and whole blood gene expres-
sion profiles for a population-based collection of individ-
uals from the capital region of Finland. Key mediators of
inflammation and allergy were shown to be correlated
with lipid levels. Further, the expressions of these genes
operated in such a highly coordinated fashion that they
appeared to function as part of a single pathway, which
itself was both highly correlated with and reactive to lipid
levels. Our findings offer insight into how lipids activate
circulating immune cells, potentially contributing to the
pathogenesis of coronary artery disease.
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Trait Chromosome Position P value
P value
(corrected) Beta (95% CI) Gene
APOB 15 48321493 9.90E-10 3.51E-05 20.39 (20.51–20.27) HDC
APOB 3 129681589 6.11E-08 2.16E-03 20.62 (20.84–20.40) GATA2
APOB 3 150097094 1.54E-07 5.45E-03 20.53 (20.73–20.34) CPA3
APOB 1 204405726 1.96E-07 6.96E-03 20.93 (21.27–20.58) C1ORF186
APOB 1 203893823 2.51E-07 8.90E-03 20.61 (20.84–20.38) SLC45A3
APOB 1 157544285 3.83E-07 1.36E-02 20.34 (20.47–20.21) FCER1A
HDL 15 48321493 5.94E-08 2.11E-03 0.35 (0.23–0.48) HDC
HDL 1 203893823 5.36E-07 1.90E-02 0.60 (0.37–0.83) SLC45A3
HDL 1 157544285 8.56E-07 3.03E-02 0.33 (0.20–0.46) FCER1A
FFA 3 48869652 1.02E-41 3.63E-37 2.85 (2.47–3.22) SLC25A20
FFA 7 95051149 1.56E-25 5.51E-21 1.41 (1.16–1.66) PDK4
FFA 11 68283656 2.97E-13 1.05E-08 2.32 (1.71–2.93) CPT1A
FFA 9 19106194 1.34E-08 4.74E-04 0.86 (0.57–1.15) ADFP
FFA 9 19106260 1.35E-08 4.79E-04 1.25 (0.83–1.67) ADFP
FFA 4 159847295 1.94E-08 6.88E-04 1.45 (0.95–1.95) ETFDH
TG 15 48321493 2.46E-37 8.71E-33 20.79 (20.90–20.68) HDC
TG 3 150097094 1.47E-31 5.22E-27 21.15 (21.33–20.97) CPA3
TG 1 203893823 1.69E-28 5.97E-24 21.28 (21.50–21.07) SLC45A3
TG 3 129681589 2.22E-28 7.88E-24 21.24 (21.45–21.04) GATA2
TG 11 59622246 2.09E-27 7.40E-23 21.62 (21.90–21.35) MS4A2
TG 1 157544285 1.11E-26 3.92E-22 20.70 (20.82–20.58) FCER1A
TG 8 33490552 8.93E-22 3.16E-17 0.81 (0.65–0.97) SNORD13
TG 11 55415610 1.06E-21 3.74E-17 21.27 (21.51–21.02) SPRYD5
TG 1 204405726 3.06E-20 1.08E-15 21.63 (21.97–21.30) C1ORF186
TG 6 26212414 3.32E-18 1.17E-13 0.80 (0.62–0.97) HIST1H4C
TG 11 59594827 1.07E-15 3.79E-11 20.78 (20.96–20.59) MS4A3
TG 21 29469766 6.16E-12 2.18E-07 20.67 (20.86–20.49) C21ORF7
TG 1 245806385 4.76E-11 1.69E-06 22.10 (22.71–21.49) C1ORF150
TG 1 45014767 9.99E-11 3.54E-06 2.51 (1.77–3.26) SNORD46
TG 12 115953221 1.16E-10 4.09E-06 1.36 (0.96–1.77) FBXW8
TG 19 50688370 3.26E-10 1.16E-05 0.96 (0.67–1.26) RTN2
TG 6 16256091 1.06E-09 3.74E-05 21.22 (21.61–20.84) MYLIP
TG 9 89330079 4.45E-09 1.58E-04 0.34 (0.23–0.46) DAPK1
TG 9 106583321 4.93E-09 1.74E-04 20.61 (20.81–20.41) ABCA1
TG 1 152230698 5.35E-09 1.90E-04 0.41 (0.28–0.55) RPS27
TG 6 34339344 2.76E-08 9.76E-04 0.53 (0.34–0.71)
TG 6 132103151 5.03E-08 1.78E-03 21.74 (22.36–21.13) ENPP3
TG 5 85949563 5.95E-08 2.11E-03 0.37 (0.24–0.50) COX7C
TG 7 134500907 6.42E-08 2.27E-03 20.59 (20.79–20.38) TMEM140
TG 19 16129952 8.98E-08 3.18E-03 20.74 (21.01–20.47) HSH2D
TG 1 190421142 2.27E-07 8.05E-03 20.53 (20.72–20.33) RGS18
TG 11 54794809 2.72E-07 9.64E-03 21.92 (22.64–21.20) TRIM48
TG 1 154248226 3.65E-07 1.29E-02 1.14 (0.71–1.57) SSR2
TG 22 17803280 4.35E-07 1.54E-02 1.35 (0.83–1.87) MRPL40
TG 12 87929168 7.78E-07 2.75E-02 21.96 (22.73–21.19) HS.132563
TG 7 65709374 8.08E-07 2.86E-02 0.47 (0.28–0.65)
TG 1 26519273 9.00E-07 3.19E-02 0.38 (0.23–0.53) CD52
TG 1 235211299 9.25E-07 3.28E-02 0.42 (0.26–0.59)
TG 8 48812282 1.29E-06 4.57E-02 20.64 (20.89–20.38) CEBPD
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28 for
FFA) and internalized by carnitine/acylcarnitine translocase
(SLC25A20, P=3.63610
237) [20]. Pyruvate dehydrogenase kinase
4( PDK4, P=5.51610
221) resides in the mitochondrial matrix and
downregulates the activity of the pyruvate dehydrogenase
complex, a process important to the substrate competition
between fatty acids and glucose [21]. Further, two strongly
associated probes lie within adipose differentiation-related protein
(ADFP, P=4.74610
24 and P=4.79610
24) which encodes
adipophilin [22,23], and electron-transferring-flavoprotein dehy-
drogenase (ETFDH, P=6.88610
24) has been previously linked to
multiple acyl-CoA dehydrogenation deficiency disorders [24].
While lipid traits were correlated with each other (Figure S1), it
was of particular interest that the top associations across APOB,
HDL and TG were largely shared (Table 3). These genes
included histidine decarboxylase (HDC), the alpha subunit from
the Fc fragment of high affinity IgE receptor (FCER1A), prostein
(SLC45A3), GATA binding protein 2 (GATA2), and carboxypep-
tidase A3 (CPA3). These genes were also significant predictors of
the APOB-APOA1 ratio, the strongest cholesterol-based risk
factor for atherosclerosis and coronary artery disease [25]
(Table 4). Differences in transcript levels between samples can
arise from the relative expansion or contraction of cell populations,
thus to test whether the associations could be due to variation in
the relative abundance of a range of blood cell types, previously
identified cell type expression markers [26] were added as
covariates in the model; significance was unchanged (Table 5).
Given inter-trait correlations, multivariate approaches may offer
better power to detect relationships between lipids and gene
expression by incorporating information from cross-trait covari-
ance [27,28] (Materials and Methods). When predicting
multiple traits simultaneously (termed meta-lipids), 85 unique
associations were observed at an equivalent Bonferroni-corrected
significance level and the above genes remained strongly
associated (Table S1). This represented an almost two-fold
increase in the number of significant associations using single lipid
traits and offered a unified ranking for assessing each gene’s
involvement in lipid levels.
The most strongly associated genes for APOB, HDL, and TG
present intriguing candidate genes for metabolic dysfunction,
inflammation, and atherosclerosis. HDC encodes the catalyst for
the conversion of histidine to histamine, a well-known pro-
inflammatory molecule that is secreted by basophils and mast cells
(BMCs). Histamine plays a role in atherogenesis and HDC
expression has been previously associated with atherosclerotic
status [29]. Importantly, lipoproteins, in particular very low-
density lipoprotein, have been shown to cause secretion of
histamine from basophils [30]. HDC may also play a more general
role in metabolic syndrome as murine knockouts display
hyperleptinemia, obesity, and glucose intolerance [31,32]. On
the cell surfaces of BMCs, FCER1A plays a powerful role in the
immune response and in histamine release as the encoded receptor
subunit directly interacts with antigen-bound IgE, an antibody
isotype capable of the most potent immune reactions [33].
FCER1A was also found to be the strongest signal in a recent
GWAS of serum IgE levels [34]. Interestingly, biochemical studies
of mast cell specific CPA3 have shown its involvement in the
degradation of APOB from LDL thus leading to the potential for
LDL fusion [35–37]. Our observation of a negative correlation
between CPA3 expression and APOB concentrations was consis-
tent with these findings. The transcription factor GATA2 has been
shown to both attenuate inflammation in murine adipose tissue
and allow for normal mast cell development [38]. Weidinger et al.
previously observed the co-expression of GATA2 and FCER1A
[34]. The correlation of FCER1A and GATA2 expression in the
DILGOM cohort was also extremely strong (Spearman’s
r=0.664), therefore we investigated the hypothesis that HDC,
FCER1A, SLC45A3, GATA2, and CPA3 function as part of the
same pathway.
Network analysis of gene co-expression and module
replication
In biological pathways, many genes tend to co-express thus it is
natural to incorporate these correlations into a network-based
framework. Within this framework, pairwise correlations between
genes are used to describe the connectedness of the network, and
clusters of tightly correlated genes (modules) can define pathways.
To construct a co-expression network that characterizes lipid
traits, the method of Horvath and Langfelder [39,40] was used to
assess the top 10% of expression signals for meta-lipids (3,520
Table 4. HDC, FCER1A, CPA3, SLC45A3, and GATA2 show significant association with the APOB/APOA1 ratio.
Trait Chromosome Position P value
P value
(corrected) Beta (95% CI) Gene
APOB/APOA1 15 48321493 3.17E-09 1.12E-04 20.39 (20.51–20.26) HDC
APOB/APOA1 1 157544285 7.28E-08 2.58E-03 20.37 (20.50–20.23) FCER1A
APOB/APOA1 1 203893823 2.29E-07 8.11E-03 20.63 (20.86–20.39) SLC45A3
APOB/APOA1 3 150097094 5.12E-07 1.81E-02 20.52 (20.72–20.32) CPA3
APOB/APOA1 3 129681589 5.40E-07 1.91E-02 20.59 (20.82–20.36) GATA2
doi:10.1371/journal.pgen.1001113.t004
Table 3. Cont.
Trait Chromosome Position P value
P value
(corrected) Beta (95% CI) Gene
TG 2 192407481 1.36E-06 4.82E-02 20.47 (20.65–20.28) SDPR
doi:10.1371/journal.pgen.1001113.t003
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modules were identified and each module’s summary expression
profile (defined by its first principal component) was tested for
correlation with individual lipid traits (Figure 1). The strongest
expression associations identified above for HDL, APOB, and
TG clustered into the same pathway, module K, hereafter
referred to as the Lipid Leukocyte (LL) module (Figure 2). The
strongest signals for FFA did not cluster into a module. Summary
expression of LL module was associated with HDL
(P=5.62 610
27), APOB (P=3.06 610
26), and TG levels
(P=2.44 610
229), results which were significant after correcting
for the estimated number of co-expression modules in the whole
gene set (Materials and Methods). It is composed of 11 genes
(12 probes) including HDC, FCER1A, GATA2, CPA3, MS4A2 (the
beta subunit of high affinity IgE receptor’s Fc fragment), SPRYD5
and SLC45A3 (Table S2). Module membership, a measure of
intramodular connectivity, showed that the afore mentioned
genes constitute the core of the module and are the most
correlated with lipid traits (Figure 3).
In order to replicate LL module’s existence and investigate
tissue specificity, we utilized expression data from the GenCord
cohort [41], a unique resource which includes both EBV-
immortalized B cell lines (LCLs) and primary T cells drawn from
individual umbilical cord blood. LL module co-expression was
highly significant in T cells, however LCLs from the same
individuals showed a marked absence of any co-expression
(Table 6). This suggests that this co-expression module is tissue
specific among blood cell types, however it is not clear whether,
or to what extent, laboratory treatment might also contribute to
the obscurity of co-expression networks. The possibility exists
that significant changes in host-cell gene expression patterns
occur upon both infection of B cells with EBV, which binds to
complement receptors thus initiating the complement system,
and the selection of B cells which have successfully integrated
episomal EBV. We therefore emphasize caution when interpret-
ing correlations in gene expression from non-primary tissues and
encourage further studies into the effects of laboratory treat-
ments.
eQTL analysis of the Lipid Leukocyte module
Gene expression itself is a quantitative trait of genetic variation
[42–44]. Using genome-wide SNP genotypes from individuals in
DILGOM, we investigated the genetic effects on expression for
each gene in LL module and for the LL module as a whole
(Materials and Methods). For those SNPs in cis, within 1 Mb
of the expression probe midpoint, a simple linear regression was
performed. In order to determine significance, a permutation
procedure was implemented [43]. For trans SNPs, greater than
5 Mb away or on a different chromosome, the non-parametric
Spearman rank correlation was used [42], offering a more robust
test of association since permutation across the whole genome
would be computationally prohibitive. To determine the signifi-
cance of the nominal Spearman P value, a threshold of 5.0610
27
was implemented.
At a permutation threshold of 0.05, only two cis SNP
associations associated with genes in LL module (Table S3),
SLC45A3 expression was associated with variation at rs12569123
and rs12569261, however there was insufficient evidence for either
SNP’s association with overall expression of the LL module
(P=0.18 and P=0.057 respectively). It was of note that
rs2251746, an experimentally verified eQTL of FCER1A and the
strongest signal in a recent GWAS for serum IgE levels [34,45],
Table 5. Significance of HDC, FCER1A, CPA3, SLC45A3, and GATA2 with cell-type specific expression markers as covariates.
Trait Chromosome Position P value P value (corrected) Beta (95% CI) Gene
APOB 15 48321493 1.62E-09 5.74E-05 20.40 (20.53–20.28) HDC
APOB 3 150097094 6.71E-08 2.38E-03 20.58 (20.79–20.37) CPA3
APOB 1 157544285 9.24E-08 3.27E-03 20.38 (20.52–20.24) FCER1A
APOB 1 203893823 1.72E-07 6.11E-03 20.66 (20.90–20.41) SLC45A3
APOB 3 129681589 5.58E-07 1.98E-02 20.60 (20.84–20.37) GATA2
HDL 15 48321493 5.13E-07 1.82E-02 0.34 (0.21–0.46) HDC
HDL 1 157544285 5.81E-07 2.06E-02 0.35 (0.22–0.49) FCER1A
HDL 1 203893823 1.34E-06 4.75E-02 0.60 (0.36–0.84) SLC45A3
FFA 3 48869652 2.11E-39 7.48E-35 2.93 (2.53–3.33) SLC25A20
FFA 7 95051149 1.72E-26 6.10E-22 1.63 (1.35–1.91) PDK4
FFA 11 68283656 8.81E-13 3.12E-08 2.32 (1.70–2.94) CPT1A
FFA 9 19106260 1.88E-08 6.66E-04 1.32 (0.87–1.77) ADFP
FFA 9 19106194 2.30E-08 8.14E-04 0.94 (0.62–1.26) ADFP
FFA 4 159847295 3.92E-07 1.39E-02 1.53 (0.95–2.11) ETFDH
TG 15 48321493 3.59E-38 1.27E-33 20.82 (20.93–20.71) HDC
TG 1 157544285 4.05E-32 1.43E-27 20.80 (20.93–20.68) FCER1A
TG 3 150097094 1.58E-31 5.60E-27 21.20 (21.38–21.01) CPA3
TG 1 203893823 1.72E-29 6.10E-25 21.36 (21.58–21.14) SLC45A3
TG 3 129681589 4.16E-28 1.47E-23 21.27 (21.49–21.06) GATA2
The linear models are the same as in Table 1 of the main text, except for the addition of covariates for each of the cell-type specific expression profiles in Whitney et al
[26]. These include proportions of lymphocytes, neutrophils, reticulocytes, B cells, cytotoxic T lymphocytes/natural killer cells, erythrocytes, myeloid cells, and Myc-
regulated cells (profiles for the time of day were also included). There were no T cell specific markers available on the Illumina HT-12. Covariates were constructed via an
average standard score across all cell-type specific markers for each sample.
doi:10.1371/journal.pgen.1001113.t005
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P=1.83610
24). In testing association with LL module expression,
rs2251746 showed strong evidence (P=4.28610
26). For trans
SNPs, only three significant associations were observed, all
between MS4A3 expression and a haploblock on chromosome 6
containing PNRC1 and SRrp35. These SNPs also strongly
predicted LL module expression (Table S4). Overall, the
strongest signal for LL module expression corresponded to
rs2251746, evidence that LL module contains both transcriptional
and genetic components of the immune response.
Structural equation modeling shows Lipid Leukocyte
module is reactive to lipids
Genetic variation can be used to orient network edges and
infer causality [46–48]. Since we have identified genetic
variation driving expression of LL module, we can construct a
directed network of core LL module and other lipid measures
which have been strongly associated with genetic variants (TG
and HDL). To do this, we use SEM as implemented in Network
Edge Orienting (NEO) methods [48]. A Local Edge Orienting
(LEO) score was calculated to infer edge orientation (Materials
and Methods). Simulation studies have previously shown that
a LEO score threshold of 0.3 corresponds to a false positive rate
less than 0.05 [48]. With this approach, we show that both HDL
and TG may be causative of LL module by driving expression of
SPRYD5 (LEO score=0.67) and MS4A2 (LEO score=0.33)
respectively (Figure 5). Interestingly, HDL also appears to
influence TG levels (LEO score=0.75). In addition, core LL
module genes were predicted to drive expression of FCER1A
(minimum LEO score=1.4) with the exception of MS4A2,h i g h
affinity IgE receptor’s beta subunit. However, for these
particular edges it should be noted that while deviation from
the causal model was at least 25 times less likely than all other
models considered, the causal model P values indicated that the
causal model itself was likely a poor fit (Table 7). As more
eQTLs are uncovered for LL module genes it is likely that
model fitting will improve and the chain of causation within LL
module will become clearer.
Conclusions
In this report, a previously uncharacterized, potentially tissue-
specific gene network (LL module) has been shown to be
associated with blood lipid levels. The LL module not only
harbors key components of inflammation and allergy which
strongly suggest a role for basophils and mast cells but also
associates with the SNP that most strongly regulates serum IgE
levels. BMCs themselves have been previously associated with
atherosclerosis and myocardial infarction [25,29,49,50], however
their precise role remains to be elucidated. The LL module
described here offers genomic evidence in support of previous
functional studies that LL module genes are linked to lipids and
metabolism and, importantly, shows that these genes operate as a
single gene module. This work provides a general framework to
understand how lipid levels might activate cellular pathways in
circulating nucleated peripheral blood cells contributing to
cascades potentially resulting in atherosclerosis. Our findings
should stimulate further, better-targeted molecular experiments to
characterize details of this link.
Figure 1. Network module associations with lipid traits. For each lipid trait and each module expression profile, a Spearman rank correlation
was performed. Each row corresponds to a module (arbitrarily lettered from A to W) and each column a particular lipid trait. Each cell contains the
probability that a correlation exists by chance and is color-coded with red indicating a strong positive correlation and green a strong negative
correlation. The module most strongly associated with lipid traits was module K. The genes composing this module, the Lipid Leukocyte (LL) module,
show that many of the top signals from a standard linear regression were part of the same sub-network.
doi:10.1371/journal.pgen.1001113.g001
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Ethics statement
The DILGOM participants provided written informed consent.
The protocol was designed and performed according to the
principles of the Helsinki Declaration and was approved by the
Coordinating Ethical Committee of the Helsinki and Uusimaa
Hospital District.
Trait measurements and sample collection
The study samples included a total of 631 unrelated Finnish
individuals aged 25–74 years from the Helsinki area, recruited
during 2007 as part of the Dietary, Lifestyle, and Genetic
determinants of Obesity and Metabolic syndrome (DILGOM)
study, an extension of the FINRISK 2007 study. Extensive trait
information was collected, including lifestyle factors. Study partic-
ipantswereasked tofastovernight(atleast10 hours)priortogivinga
blood sample. After extraction, the blood samples were left at room
temperature for 45 minutes then centrifuged to separate the serum
and plasma. Samples were kept in a 270uCf r e e z e r .
Total serum cholesterol (TC), high density lipoprotein choles-
terol (HDL), low density lipoprotein cholesterol (LDL), apolipo-
protein B (APOB), apolipoprotein A1 (APOA1), triglycerides (TG),
and fasting free fatty acid (FFA) levels were determined in the
Laboratory of Analytical Biochemistry of the Institute of Health
and Welfare (Helsinki, Finland). TC measurements were carried
out with the CHODPAP-assay (Abbott Laboratories, Abbott Park,
Illinois, USA). HDL measurements used a direct enzymatic assay
(Abbott Laboratories, Abbott Park, Illinois, USA). TG was
measured with the enzymatic GPO assay (Abbott Laboratories,
Abbott Park, Illinois, USA). APOB and APOA1 levels were
determined using an immunoturbidometric method (Abbott
Laboratories, Abbott Park, Illinois, USA). For APOB, the
coefficients of variation (CVs) were 3.8%, 3.4% and 2.1% at the
levels 0.35 g/L, 0.90 g/L and 1.66 g/L respectively. For APOA1,
the CVs were 2.0%, 1.4% and 1.6% at the levels 0.91 g/L,
1.19 g/L and 2.15 g/L respectively. All methods used manufac-
turer protocols. FFA was determined using the enzymatic
colorimetric ACS-ACOD method, as implemented in the
NEFA-C assay kit, using the Architect c8000 (Abbott Laborato-
ries, Abbott Park, Illinois, USA). Between series repeatability were
0.73 mmol/L, CV=2.4% (n=143) for level 1 and 0.99 mmol/L,
CV=2.3% (n=139) for level 2. All methods used manufacturer
protocols.
Genotyping and expression microarrays
DNA was extracted from 10 ml EDTA whole blood samples
with salt precipitation using Autopure (Qiagen GmbH, Hilden,
Germany). DNA purity and quantity were assessed with Pico-
Green (Invitrogen, Carlsbad, CA, USA). Genotyping used 250 ng
of DNA and proceeded on the Illumina 610-Quad SNP array
(Illumina Inc., San Diego, CA, USA) using standard protocols.
Figure 2. Topology of the network and the LL module. The co-expression patterns of the network and the LL module were rendered using
BiolayoutExpress3D [60]. Each node is a gene (node size is not significant) and each edge is colored according to the absolute value of the Pearson
correlation between two nodes, red being strong and blue being weak. The LL module has been colored yellow and, within the topology of the
network (right panel), has been enlarged relative to other nodes. The topology of the network has been edge filtered (Pearson,0.65) in order to
make strong correlations clearer.
doi:10.1371/journal.pgen.1001113.g002
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determined by visual inspection of a 0.75% agarose gel or low
Sequenom call rate), 555 samples were successfully genotyped.
To obtain stabilized total RNA, we used the PAXgene Blood
RNA System (PreAnalytiX GMbH, Hombrechtikon, Switzerland),
which included collection of 2.5 ml peripheral blood into
PAXgene Blood RNA Tubes (Becton Dickinson and Co., Franklin
Lakes, NJ, USA) and total RNA extraction with PAXgene Blood
RNA Kit (Qiagen GmbH, Hilden, Germany). We used the
protocol as recommended by the manufacturer.
The integrity and quantity of the RNA sample was evaluated
with the 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA, USA). Biotinylated cRNA was produced from 200 ng of total
RNA with Ambion Illumina TotalPrep RNA Amplification Kit
(Applied Biosystems, Foster City, CA, USA), using the protocol
specified by the manufacturer. 750 ng of biotinylated cRNA were
hybridized onto Illumina HumanHT-12 Expression BeadChips
(Illumina Inc., San Diego, CA, USA), using standard protocol. For
each sample, biotinylated cRNA preparation and hybridization
onto BeadChip were done in duplicates. For expression arrays,
585 samples were successfully completed.
Data quality, processing and imputation
After each expression array was scanned, background corrected
probe signal intensities and bead counts were outputted from
Illumina’s BeadStudio software in order to undergo further
processing. Strip-level quantile normalization was then used to
force probe intensity distributions for all samples on all arrays to be
the same [51]. Since each sample was technically replicated, the
normalized values were then used to measure their correlation via
Pearson’s product moment correlation coefficient (R) and Spear-
man’s rank correlation coefficient (r). Generally, reproducibility
was high (Figure S2). To further assess data quality, we also
generated MA plots between replicate arrays after normalization
[52]. We manually inspected each sample’s MA plot for curvature
or overt deviation from the M=0 axis, none exhibited these
characteristics. A sample was removed from further analysis if its R
was ,0.94 or r was ,0.60 (9 samples fail).
To combine raw signal intensities from corresponding repli-
cates, the signals (S) were weighted by the number of beads (b)
contributing to each signal and summed to arrive at one measure
of signal intensity (d) for each sample at each probe:
d~S1
b1
b1zb2
  
zS2
b2
b1zb2
  
Probes that did not meet certain criteria were removed from
further analysis: (a) non-autosomal (b) complementary to cDNA
from erythrocyte globin components (c) map to more than one
genomic position.
For each genotyping array, Cy3 and Cy5 signal intensities were
exported from BeadStudio and pooled together for clustering with
the Illuminus genotype calling algorithm [53]. Samples were
removed from further analysis if they showed low quality (call rate
,0.95, 19 samples removed), failed to match Sequenom genotype
fingerprinting (concordance ,0.90 for at least 10 genotypes, 0
Figure 3. Connectivity and trait association within the LL module. In the LL module, there is a strong positive correlation between the intra-
modular connectivity of a node (gene) and its association with APOB, HDL, and TG levels, showing that the approximately eight genes inter-
connected are also the most associated with lipid traits. These genes constitute the core of the LL module.
doi:10.1371/journal.pgen.1001113.g003
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duplication (pairwise identity by descent pi-hat .0.10, 1 sample
removed). SNPs failing to meet the following quality thresholds
were also removed from further analysis: call rate .0.95, minor
allele frequency .0.01, and Hardy-Weinberg equilibrium P value
.1.0610
26. 37,558 SNPs were removed in total.
Table 6. LL module core gene co-expression in the GenCord cohort.
DILGOM (whole blood) GenCord (T cells) GenChord (LCLs)
Gene A Gene B Spearman rho P value Spearman rho P value Spearman rho P value
CPA3 FCER1A 0.701 ,2.2E-16 0.917 ,2.2E-16 20.055 0.636235841
CPA3 GATA2 0.705 ,2.2E-16 0.917 ,2.2E-16 0.035 0.767344119
CPA3 HDC 0.774 ,2.2E-16 0.650 ,2.2E-16 0.060 0.607446891
CPA3 MS4A2 0.682 ,2.2E-16 0.866 ,2.2E-16 0.135 0.246666555
CPA3 SLC45A3 0.812 ,2.2E-16 0.843 ,2.2E-16 0.058 0.618207944
CPA3 SPRYD5 0.619 ,2.2E-16 0.160 0.168711659 20.060 0.607702148
FCER1A CPA3 0.701 ,2.2E-16 0.917 ,2.2E-16 20.055 0.636235841
FCER1A GATA2 0.657 ,2.2E-16 0.858 ,2.2E-16 20.104 0.375296225
FCER1A HDC 0.684 ,2.2E-16 0.576 1.18E-07 20.115 0.325281824
FCER1A MS4A2 0.734 ,2.2E-16 0.880 ,2.2E-16 20.319 0.005509442
FCER1A SLC45A3 0.651 ,2.2E-16 0.852 ,2.2E-16 0.006 0.961262695
FCER1A SPRYD5 0.605 ,2.2E-16 0.237 0.041109859 0.276 0.016997624
GATA2 CPA3 0.705 ,2.2E-16 0.917 ,2.2E-16 0.035 0.767344119
GATA2 FCER1A 0.657 ,2.2E-16 0.858 ,2.2E-16 20.104 0.375296225
GATA2 HDC 0.890 ,2.2E-16 0.655 ,2.2E-16 0.104 0.371949805
GATA2 MS4A2 0.739 ,2.2E-16 0.882 ,2.2E-16 20.009 0.935643163
GATA2 SLC45A3 0.828 ,2.2E-16 0.795 ,2.2E-16 0.086 0.464335679
GATA2 SPRYD5 0.762 ,2.2E-16 0.055 0.638233048 20.063 0.591125476
HDC CPA3 0.774 ,2.2E-16 0.650 ,2.2E-16 0.060 0.607446891
HDC FCER1A 0.684 ,2.2E-16 0.576 1.18E-07 20.115 0.325281824
HDC GATA2 0.890 ,2.2E-16 0.655 ,2.2E-16 0.104 0.371949805
HDC MS4A2 0.770 ,2.2E-16 0.623 3.99E-09 0.020 0.865198439
HDC SLC45A3 0.856 ,2.2E-16 0.599 2.82E-08 20.277 0.016265791
HDC SPRYD5 0.791 ,2.2E-16 20.056 0.630865052 20.171 0.141566903
MS4A2 CPA3 0.682 ,2.2E-16 0.866 ,2.2E-16 0.135 0.246666555
MS4A2 FCER1A 0.734 ,2.2E-16 0.880 ,2.2E-16 20.319 0.005509442
MS4A2 GATA2 0.739 ,2.2E-16 0.882 ,2.2E-16 20.009 0.935643163
MS4A2 HDC 0.770 ,2.2E-16 0.623 3.99E-09 0.020 0.865198439
MS4A2 SLC45A3 0.718 ,2.2E-16 0.783 ,2.2E-16 20.003 0.981884832
MS4A2 SPRYD5 0.674 ,2.2E-16 0.199 0.087013944 20.347 0.002401304
SLC45A3 CPA3 0.812 ,2.2E-16 0.843 ,2.2E-16 0.058 0.618207944
SLC45A3 FCER1A 0.651 ,2.2E-16 0.852 ,2.2E-16 0.006 0.961262695
SLC45A3 GATA2 0.828 ,2.2E-16 0.795 ,2.2E-16 0.086 0.464335679
SLC45A3 HDC 0.856 ,2.2E-16 0.599 2.82E-08 20.277 0.016265791
SLC45A3 MS4A2 0.718 ,2.2E-16 0.783 ,2.2E-16 20.003 0.981884832
SLC45A3 SPRYD5 0.758 ,2.2E-16 0.202 0.082789037 0.083 0.479958577
SPRYD5 CPA3 0.619 ,2.2E-16 0.160 0.168711659 20.060 0.607702148
SPRYD5 FCER1A 0.605 ,2.2E-16 0.237 0.041109859 0.276 0.016997624
SPRYD5 GATA2 0.762 ,2.2E-16 0.055 0.638233048 20.063 0.591125476
SPRYD5 HDC 0.791 ,2.2E-16 20.056 0.630865052 20.171 0.141566903
SPRYD5 MS4A2 0.674 ,2.2E-16 0.199 0.087013944 20.347 0.002401304
SPRYD5 SLC45A3 0.758 ,2.2E-16 0.202 0.082789037 0.083 0.479958577
Each core gene in the LL module was tested for co-expression against all other core genes in the LL module using Spearman’s rank correlation coefficient. This was done
across three datasets: whole blood extracts from the DILGOM cohort (N=518), primary T cells from GenChord individuals (N=75), and EBV-transformed B cells from the
same GenCord individuals. Given 21 tests for each cohort, the Bonferroni corrected significance level is 2.38610
23.
doi:10.1371/journal.pgen.1001113.t006
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PLoS Genetics | www.plosgenetics.org 9 September 2010 | Volume 6 | Issue 9 | e1001113Figure 4. Association of genetic variation with expression of FCER1A and SLC45A3.For each cis SNP proximal to FCER1A and SLC45A3, a simple linear
model is fitted and the regression Pvalue (2log10 transformed)plotted along thevertical axiswith genomic position of the SNPalong the horizontal axis (both
on chromosome 1). The two adjacent SNPs passing a permutation threshold of 0.05 are denoted by red dots while the SNP (rs2251746) withinFCER1A found to
drive expression of the LL module is circled in red. The position of the expression probe and the direction of transcription are denoted by a green arrow.
doi:10.1371/journal.pgen.1001113.g004
Figure 5. The directed network of core LL module, HDL, and triglycerides. NEO was used to generate an edge-oriented network of
triglycerides, HDL, and core LL module genes. Blue edges denote significant correlations between SNPs and nodes (orange circles), black edges denote
significantcorrelations between nodes with a correspondingLEOscore greater than 0.3 (predictedas a causal edge) while grey edges denote significant
correlations between nodes with a LEO score less than 0.3 (causality is inconclusive). Dotted edges signify causal model fitted P values ,0.05.
doi:10.1371/journal.pgen.1001113.g005
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version 5 using phased HapMap release 22 haplotypes from the
CEU panel [54]. A genotype was assigned if its posterior
probability was .0.95 or missing if not, and all SNPs
underwent the same filtering as those above. 249,345 SNPs
were removed in total, leaving 2,061,516 SNPs for further
analysis.
Population structure
To control for structure in the Finnish population, we used
principal components analysis (PCA) on the genotypic data in
order to identify outliers who descend from outside the Helsinki
region (Figure S3). All SNPs underwent PCA with the
EIGENSOFT software [55]; regression residuals involving the 2
previous SNPs were used as inputs to correct for SNP linkage
Table 7. LL core directed network statistics.
Edge (ARB) LEO score (LEO.NB.OCA) Model P value (ARB) Pearson Path Z statistic
HDLRTG 0.746 0.888 20.34 28.22
HDLRSPRYD5 0.671 0.466 0.19 4.52
TGRMS4A2 0.334 0.825 20.45 211.4
FCER1ARHDL 0.29 0.718 0.23 5.69
HDLRHDC 0.259 0.732 0.24 5.59
TGRCPA3 0.214 0.676 20.49 213
FCER1ARMS4A2 0.259 0.135 0.74 25.3
SPRYD5RFCER1A 1.41 1.35E-05 0.62 18.1
HDCRFCER1A 1.76 5.84E-06 0.7 22.2
CPA3RFCER1A 2.31 1.93E-06 0.71 23.1
SLC45A3RFCER1A 2.53 1.48E-06 0.66 20
GATA2RFCER1A 3.54 3.32E-08 0.67 20.3
MS4A2RHDL 26.22 3.75E-07 0.17 3.87
GATA2RHDL 26.29 5.15E-07 0.2 4.56
SLC45A3RHDL 26.02 6.86E-07 0.22 5.15
CPA3RHDL 26.06 6.85E-07 0.19 4.5
HDCRHDL 25.8 1.17E-06 0.24 5.59
SPRYD5RHDL 25.24 2.69E-06 0.19 4.52
MS4A2RFCER1A 20.259 0.000297 0.74 25.3
FCER1ARGATA2 24.15 4.33E-05 0.67 20.3
FCER1ARSLC45A3 22.53 0.00245 0.66 20
FCER1ARCPA3 22.31 0.00274 0.71 23.1
GATA2RTG 22.23 0.00431 20.45 211.5
FCER1ARTG 20.035 0.288 20.45 211.4
SLC45A3RTG 22.22 0.00504 20.46 211.8
SPRYD5RTG 22.1 0.00585 20.4 29.9
FCER1ARHDC 21.76 0.00796 0.7 22.2
HDCRTG 21.94 0.00887 20.51 213.6
FCER1ARSPRYD5 21.41 0.0224 0.62 18.1
CPA3RTG 21.48 0.0225 20.49 213
MS4A2RTG 21.51 0.0255 20.45 211.4
TGRFCER1A 20.224 0.186 20.45 211.4
TGRGATA2 20.826 0.109 20.45 211.5
HDLRSLC45A3 20.204 0.451 0.22 5.15
HDLRMS4A2 20.553 0.175 0.17 3.87
TGRHDL 20.884 0.116 20.34 27.85
TGRSPRYD5 20.671 0.156 20.4 29.9
HDLRCPA3 20.223 0.475 0.19 4.5
HDLRFCER1A 20.616 0.174 0.23 5.34
TGRSLC45A3 20.783 0.137 20.46 211.8
TGRHDC 20.464 0.268 20.51 213.6
HDLRGATA2 20.495 0.319 0.2 4.56
doi:10.1371/journal.pgen.1001113.t007
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any statistically significant principal component were removed
from further analysis (Figure S4, 17 samples removed). A
principal component was considered significant if its Tracy-
Widom P value was ,0.01.
Trait distributions and correlations
Trait distributions and inter-trait correlations were also
examined. Given well-known gender differences between many
of the traits, distributions for males and females were treated
separately. If a trait was not normally distributed as determined by
an Anderson-Darling test (P,0.01), a Box-Cox power transfor-
mation was implemented to achieve normality and each trait
measurement was converted to a Z score. The Z scores for males
and females were then combined for further analyses. Inter-trait
correlations were calculated via Spearman’s rank correlation
coefficient, see Figure S1.
Association analysis and multiple test correction
All univariate statistical tests and permutations were done using
PopGenomix, a C++ package developed in the Dermitzakis
laboratory for the analysis of gene expression data. To test the
association of a transcript’s expression with a given SNP, linear
regression was used. A simple model was constructed where Yi is
the probe’s log2-normalized expression for individual i, Xi is the
genotype of the individual at a given SNP (encoded as 0, 1, or 2 for
the number of minor alleles), and ei is a normally distributed
random variable with mean equal to zero and constant variance:
Yi~azbXizei
Nominal P values were calculated for the test of no association,
b=0.
In the case of Spearman’s r, the coefficient is a function of
ranks, xi is the rank of the log2-normalized expression value for
individual i, yi is the genotypic rank (0, 1, or 2), and n is the
corresponding number of measurements:
r~1{
6
P
xi{yi ðÞ
2
nn 2{1 ðÞ
Since sample sizes were large, a t-test with n-2 degrees of freedom
was used to determine a nominal P value.
Null distributions of P values were generated in order to
evaluate the significance of the observed P value [43,56], with
expression levels permuted relative to genotypes. Unless otherwise
specified, 10,000 permutations were performed, and each test was
considered at an alpha level of 0.05.
Multiple and multivariate modeling was done using the R
statistical computing language (http://www.r-project.org/). To
test the association of a transcript’s expression with a given trait,
linear regression was used with appropriate covariates that include
age, gender, or other correlated traits (see Table 2).
Given the highly correlated nature of the trait measurements,
the construction of meta-traits was investigated. The meta-lipids
(TC, FFA, HDL, LDL, TG, APOB, APOA1) trait was treated as
the response variable in a multivariate linear model with probe
expression, age, hypertension medication, and cholesterol medi-
cation as regressors (Table 2).
Y~XbzE
where Y is a matrix of normalized individual lipid trait values for
genes; X is a matrix of log2-normalized expression values, age
values, hypertension and cholesterol medication (as factors) for each
individual; and E is a data matrix of error terms. Similarly, when
testing SNP association with expression of all LL module genes
simultaneously, a simple multivariate linear model was used. In
which case Y is a matrix of log2-normalized individual expression
values for genes in LL module, X is a vector of individual SNP
genotypes (encoded 0, 1, 2), and E is a data matrix of error terms.
Reported P values are from the Wilks’ lambda test statistic [57].
Multiple and multivariate modeling use the Bonferroni correction
to control for multiple tests. All reported P values are corrected
unless otherwise noted.
Correction for cell type expression markers
To correct for relative cell type numbers, we use the expression
markers defined in Whitney et al. [26]. The cell type proportions
corrected for include lymphocytes, neutrophils, reticulocytes, B
cells, cytotoxic T lymphocytes/natural killer cells, erythrocytes,
myeloid cells, and Myc-regulated cells (profiles for the time of day
were also included), however correction for T cells (uncovered on
HT-12 array), mast cells (not assessed in Whitney et al.), and
basophils specific markers (not assessed in Whitney et al.) was not
possible. Covariates for the cell types were defined as the average
standard score across all cell-type specific markers for each sample.
Network analysis
Network analysis was done using the R packages, WGCNA
[39,40,58] and NEO [48].
The undirected transcription network considered the top 10%
of expression signals for meta-lipids (3,520 unique signals). The
correlation matrix was constructed via all against all Pearson
correlation coefficient calculations and the adjacency matrix was
calculated with a soft threshold power of nine (Figure S5). Genes
were then hierarchically clustered and visualized in a dendrogram
(Figure S6), where a ‘leaf’ constitutes an individual gene and
‘branches’ are clusters of tightly correlated genes. The dynamic
tree cut function in WGCNA with a minimum module size of 10
genes was used to determine initial modules. Individual module
expression profiles underwent singular value decomposition and
the summary module profiles from the vector corresponding to the
first singular value were clustered to identify modules that were
highly correlated (those less than a dendrogram height of 0.20).
These modules were then merged.
To correlate module summary profiles with lipid traits, a t-test
of Spearman’s rank correlation was used. The corresponding
Spearman correlation coefficients and P values can be observed in
Figure 1. Statistical significance was determined by estimating the
number of co-expression modules in the entire dataset. Given the
23 modules calculated from 1000 expression probes, we estimated
the total number of modules to be (23635419/1000)=814.637.
Therefore, the appropriate alpha level was determined to be
(0.05/814.637)=6.14610
25. Calculations of module membership
and individual gene significance (Figure 3) have been previously
defined [39]. Only module K (the Lipid Leukocyte, LL, module)
was used in further analyses.
NEO was used to predict the directedness of the network using
causal SNPs as anchors. Of the lipid traits associated with LL
module expression, HDL and TG were selected because the
genetic variation underlying them has been studied extensively.
Since the choice of SNPs can have a large impact on the
directedness of the network (non-causal SNPs can introduce
noise) and the DILGOM dataset (N=518) is not sufficiently
powered to significantly detect many of the known variants, we
use only the strongest signals from recent genome-wide
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HDL and rs1260326 (GCKR) was included for TG. In our
dataset, the strongest signal previously found for TG, rs964184
(APOA1-C3-A4-A5), did not pass quality control filters. Since
rs2251746 has been shown to be an eQTL for FCER1A and LL
module expression, we also include it as a causal anchor. To
further verify that these loci can be considered causal anchors in
the DILGOM dataset, we adopt the automatic SNP selection
approach in NEO using both a greedy method and forward-
stepwise regression [48]. We observed that all SNPs were
correctly assigned to their respective nodes. An edge exists if
the edge score (the absolute value of the Pearson correlation
between nodes A and B) exceeds a threshold of 0.3. Since all
nodes have a causal anchor, the NEO score (the log10 ratio of a
fitted causal model P value to the next best causal model P value)
defined in the main text is the NEO.NB.OCA score. An edge is
considered significantly oriented if the NEO score exceeds a
threshold of 0.3. Simulation studies have shown that a
NEO.NB.OCA score of 0.3 or more corresponds to a false
positive rate of 5% or less (cite NEO). We further considered the
path coefficient for ARB( Z test statistic .1.96 or ,21.96) and,
since the NEO score is a ratio of model P values, the fit of the
primary model MARARBrMB (P value should be .0.05). See
Table 7 for directed network edge statistics.
Data availability
The expression data for the individuals analyzed in this study
has been made publicly available through the ArrayExpress
database (accession number E-TABM-1036).
Supporting Information
Figure S1 Inter-trait correlations from the DILGOM popula-
tion sample. Each tile is the color-coded Spearman rank
correlation coefficient between any two trait measurements across
the assessed DILGOM samples. Using the color bar on the right, a
red tile indicates a strong positive correlation while a green tile
indicates a strong negative correlation. No inter-trait correlation is
signified by a white tile (the main diagonal is white by default).
Found at: doi:10.1371/journal.pgen.1001113.s001 (0.24 MB
TIF)
Figure S2 Pearson and Spearman correlation coefficient
distributions for technical replicates. Technical replicates of the
Illumina HT-12 expression arrays displayed high reproducibility.
Found at: doi:10.1371/journal.pgen.1001113.s002 (0.13 MB TIF)
Figure S3 PCA of genotype data with no outliers removed.
Principal components analysis was used to identify ethnically
outlying samples.
Found at: doi:10.1371/journal.pgen.1001113.s003 (0.13 MB TIF)
Figure S4 PCA of genotype data after ethnic outlier removal.
Seventeen samples were identified as ethnically differentiated from
the rest of the DILGOM cohort (see Materials and Methods).
After removal, the cohort shows no significant population
structure.
Found at: doi:10.1371/journal.pgen.1001113.s004 (0.24 MB TIF)
Figure S5 Selection of adjacency matrix soft threshold power.
To better differentiate strong and weak correlations and
approximate scale-free network topology, each element of the
expression correlation matrix is raised to a power b. Here, the
selection of b follows the following criteria [58] (a) it maximizes the
connectivity of network and (b) approximates scale-free network
topology at a signed R
2.0.80.
Found at: doi:10.1371/journal.pgen.1001113.s005 (0.15 MB TIF)
Figure S6 Transcription network dendrogram and module
determination. Modules are determined via hierarchical clustering
and dynamic branch cutting with a minimum module size of 10
genes. The module assignments are color-coded under ‘Dynamic
Tree Cut’. Since initial branch cutting can produce modules which
are themselves correlated with each other, a module merging step
was implemented where all modules underwent singular value
decompositions and were clustered [39]. The merged modules are
color-coded under ‘Merged dynamic’. After merging, 23 modules
were taken forward for further analysis.
Found at: doi:10.1371/journal.pgen.1001113.s006 (1.23 MB TIF)
Table S1 Genes showing significant evidence of association with
lipid meta-trait.
Found at: doi:10.1371/journal.pgen.1001113.s007 (0.04 MB
XLS)
Table S2 Genes comprising the LL module.
Found at: doi:10.1371/journal.pgen.1001113.s008 (0.02 MB
XLS)
Table S3 Cis expression quantitative trait loci in the LL module.
Found at: doi:10.1371/journal.pgen.1001113.s009 (0.02 MB
XLS)
Table S4 Trans expression quantitative trait loci in the LL
module.
Found at: doi:10.1371/journal.pgen.1001113.s010 (0.02 MB
XLS)
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